T cell dependence of chronic destructive murine arthritis induced by repeated local activation of toll-like receptor-driven pathways

被引:63
作者
Joosten, Leo A. B. [1 ]
Abdollahi-Roodsaz, Shahla [1 ]
Heuvelmans-Jacobs, Marleen [1 ]
Helsen, Monique M. A. [1 ]
van den Bersselaar, Liduine A. M. [1 ]
Oppers-Walgreen, Birgitte [1 ]
Koenders, Marije I. [1 ]
van den Berg, Wirn B. [1 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Dept Rheumatol, NL-6500 HB Nijmegen, Netherlands
来源
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 01期
关键词
D O I
10.1002/art.23152
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The pathogenesis of rheumatoid arthritis is often linked to bacterial infections. The present study was undertaken to develop a mouse model of chronic destructive arthritis induced by repeated intra-articular (IA) exposure to bacterial cell wall fragments and to investigate the cytokine dependence of this model. Methods. Mice that were deficient in various cytokines were injected IA with cell wall fragments of Streptococcus pyogenes on days 0, 7, 14, and 21. The development of chronic destructive arthritis was comp ared between groups of mice lacking different cytokines, to assess which cytokines were crucial for development of chronic destructive arthritis. Results. Repeated exposure of a joint to S pyogenes cell wall fragments resulted in the development of chronic destructive arthritis. In mice deficient in recombination-activating gene 2, streptococcal cell wall (SCW)-directed T cell reactivity was found and chronic arthritis did not develop, implicating T cells in the generation of chronic SCW-induced arthritis. Interleukin-17 (IL-17) receptor-deficient mice showed a reduction of joint destruction in the chronic stage, implicating a detrimental role of the recently discovered IL-17-producing T helper cells (Th17 cells). IL-23 expression was apparent during the late stages of arthritis. Joint swelling was no longer dependent on tumor necrosis factor a (TNF alpha) after the last flare, and pronounced cartilage damage was found after 28 days in TNF alpha-deficient mice. In contrast, IL-1 beta-deficient mice were fully protected against joint swelling and cartilage and bone destruction during the late stages of disease. Conclusion. These findings indicate that the TNF alpha dependence of arthritis is lost during the erosive stage, when Th17 cells become crucial. IL-I beta dependence remains strong, consistent with its pivotal role in the generation of Th17 cells.
引用
收藏
页码:98 / 108
页数:11
相关论文
共 50 条
  • [1] Toll-like receptors: critical proteins linking innate and acquired immunity
    Akira, S
    Takeda, K
    Kaisho, T
    [J]. NATURE IMMUNOLOGY, 2001, 2 (08) : 675 - 680
  • [2] Alten RHE, 2006, ANN RHEUM DIS, V65, P60
  • [3] The toll-like receptor-nuclear factor κB pathway in rheumatoid arthritis
    Andreakos, E
    Sacre, S
    Foxwell, BM
    Feldmann, M
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 2478 - 2488
  • [4] The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles
    Andrei, C
    Dazzi, C
    Lotti, L
    Torrisi, MR
    Chimini, G
    Rubartelli, A
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (05) : 1463 - 1475
  • [5] INHIBITION OF THE PRODUCTION AND EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN RHEUMATOID-ARTHRITIS
    AREND, WP
    DAYER, JM
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (02): : 151 - 160
  • [6] Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses
    Beg, AA
    [J]. TRENDS IN IMMUNOLOGY, 2002, 23 (11) : 509 - 512
  • [7] Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
    Bongartz, T
    Sutton, AJ
    Sweeting, MJ
    Buchan, I
    Matteson, EL
    Montori, V
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (19): : 2275 - 2285
  • [8] Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2482
  • [9] Targeting IL-1 in inflammatory disease: New opportunities for therapeutic intervention
    Braddock, M
    Quinn, A
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) : 1 - 10
  • [10] BRENNAN FM, 1989, LANCET, V2, P244